1 Product identity
Ingredient risk
1 ingredient to use with caution
Ultra Guggulow
BrandDoctor's Best→Botanical Tablet or Pill 8 ingredients 1 caution DSLD #25029Net contents: 90 Tablet(s)
Target: Adults and Children 4 years and above
DSLD entry: 2013-08-23
2 Ingredients (8)
IngredientGroupSafety
Black Pepper extractBlack Pepper—
CelluloseCellulose—
Stearic AcidStearic Acid—
Ingredient amounts require the full DSLD label. View full label at NIH DSLD →
⚠️ Use with caution — restricted in some markets
Magnesium — Severe deficiency (<0.50 mmol/L) causes secondary hypocalcemia and hypokalemia that will not correct until magnesium is repleted first [1].
3 Safety cross-reference
Guggul — Limited Evidence
⚠ GI upset, headache
⚠ Thyroid stimulation
Sodium — Limited Evidence
⚠ Hypertension
⚠ Fluid retention
Silicon — Generally Safe
⚠ Very low toxicity
Magnesium — Use with Caution
⚠ Diarrhea (especially oxide)
⚠ Accumulates in renal impairment
4 Label claims
• All Other
• Structure/Function
5 Data source
DSLD ID25029
Full labelView at NIH DSLD →
SourceOffice of Dietary Supplements, NIH
Market statusOn market
Entry date2013-08-23
6 More from Doctor's Best
View Doctor's Best Safety Scorecard → 152 products
5-HTP 100 mg5-HTP Enhanced with Vitamins B6 and CAcetyl-L-CarnitineAcetyl-L-Carnitine With Biosint Carnitines 500 mgAlpha-Lipoic Acid 600Ashwagandha With Sensoril 125 mg7 Cite this page
Vancouver
Pkhakadze G. Ultra Guggulow — product analysis [Internet]. Tbilisi: Public Health Institute of Georgia; 2026 [cited 2026 Aug 24]. Available from: https://supplement.ge/products/ultra-guggulow-25029/
CC BY 4.0. Product data from NIH DSLD; safety analysis by SupplementIndex.
GP
Analyzed by SupplementIndex
PHIG · Editor-in-Chief: Prof. Giorgi Pkhakadze, MD, MPH, PhD
Product data sourced from the NIH Dietary Supplement Label Database (DSLD). Safety cross-referencing by SupplementIndex. This analysis is for informational purposes only. For corrections: info@accreditation.ge.
Publisher: PHIG
Publisher: PHIG